Johnson & Johnson Wound Management Announces the Latest Addition to Family of Matrix Dressings Designed to Treat Chronic Wounds

SOMERVILLE, N.J. -- Johnson & Johnson Wound Management today announced PROMOGRAN PRISMA* Matrix as the latest addition to its family of chronic wound dressings. Developed to provide protection and growth in a changing wound environment, PRISMA Matrix absorbs destructive components of wound exudate while promoting healthy tissue healing.

The unique combination of collagen, oxidized regenerated cellulose (ORC)

and silver-ORC+ delivers a balanced combination of protection and growth for a

variety of wound types and conditions at any exudate level. PRISMA Matrix

removes destructive elements and components in wound fluid, kills clinically

relevant bacteria in the dressing to help maintain bacterial balance and

reduces bacterial growth, which may reduce the risk of infection. The dressing

also promotes healthy tissue growth while delivering silver to the wound. The

collagen provides a biodegradable matrix for cellular invasion and capillary

growth while creating an environment that promotes the formation of

granulation tissue, epithelialization and optimal wound healing.

"With PRISMA Matrix, Johnson & Johnson Wound Management continues its

pioneering role as a wound care industry leader," states William Li, MD,

president of the Angiogenesis Foundation in Cambridge, Mass. "This single

product is an integrated technology that addresses multiple factors causing

impaired healing. PRISMA Matrix can be used as part of the standard approach

to restoring proper balance in the wound bed to promote successful healing."

PRISMA Matrix is intended for the management of exuding wounds. Under the

supervision of a healthcare professional, PRISMA Matrix may be used for the

management of diabetic, venous and pressure ulcers, ulcers caused by mixed

vascular etiologies, full -- and partial-thickness wounds, donor sites and

other bleeding surface wounds, abrasions, traumatic wounds healing by

secondary intention and dehisced surgical wounds. PRISMA Matrix may be used

under compression therapy with healthcare professional supervision.

PRISMA Matrix is not indicated for third-degree burns or patients with

known sensitivity to silver, ORC or collagen. PRISMA Matrix may be used when

visible signs of infection are present in the wound area only when proper

medical treatment addresses the underlying cause. PRISMA Matrix is not

intended to be a substitute for appropriate treatment of infection.

* Trademark

+ Silver-ORC contains 0.25 percent ionically-bound silver.

Source: Johnson & Johnson Wound Management